← All organizations
Highest phase reached
Phase 1
First clinical trial
Feb 1, 2018Last known activity
Feb 15, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 4 trials)
Phase 1 (7 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (17)
- NCT06307249OfficialPhase 1Feb 15, 2023
- NCT06307249Lead sponsorPhase 1Feb 15, 2023
- NCT06307249Sponsor investigatorPhase 1Feb 15, 2023
- NCT05925140Sponsor investigatorPhase 1Mar 28, 2020
- NCT05925140Lead sponsorPhase 1Mar 28, 2020
- NCT05925140Reponsible party - principal investigatorPhase 1Mar 28, 2020
- NCT05925140Study chairPhase 1Mar 28, 2020
- NCT05925140OfficialPhase 1Mar 28, 2020
- NCT06065592Study chairPhase 1Feb 1, 2019
- NCT06065592OfficialPhase 1Feb 1, 2019
- NCT06065592Lead sponsorPhase 1Feb 1, 2019
- NCT06065592Sponsor investigatorPhase 1Feb 1, 2019
- NCT06065592Reponsible party - principal investigatorPhase 1Feb 1, 2019
- NCT04071574Lead sponsorN/AFeb 1, 2018
- NCT04071574Reponsible party - principal investigatorN/AFeb 1, 2018
Details
- Last known activity
- Feb 15, 2023